CN1034580A - The manufacture method of a kind of antiparasitic new antibiotic and its esters - Google Patents
The manufacture method of a kind of antiparasitic new antibiotic and its esters Download PDFInfo
- Publication number
- CN1034580A CN1034580A CN 88100187 CN88100187A CN1034580A CN 1034580 A CN1034580 A CN 1034580A CN 88100187 CN88100187 CN 88100187 CN 88100187 A CN88100187 A CN 88100187A CN 1034580 A CN1034580 A CN 1034580A
- Authority
- CN
- China
- Prior art keywords
- culture
- extract
- antiparasitic
- prepared
- manufacturing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
一种抗寄生虫新抗生素及其盐类的制造方法,其 特点是,从KP-197菌株培养物中,用溶媒法分离, 提取和精制出具有抗寄生虫活性的两种物质。该特 质的抗寄生虫活性明显高于已知药物,而其毒性却低 于已知药物,故可成为治疗人、动物和植物寄生虫的 有效药物。A kind of manufacture method of antiparasitic novel antibiotic and its salt, its It is characterized in that, from the KP-197 strain culture, it is separated by solvent method, Two substances with antiparasitic activity are extracted and refined. The special The qualitative antiparasitic activity is significantly higher than that of known drugs, while its toxicity is low Because of known drugs, it can be used as a treatment for human, animal and plant parasites effective drug.
Description
本发明涉及一种能从微生物培养物中提取抗寄生虫的新抗生物质戒台霉素(JEITACINS)及其盐类的制造方法。该抗生素及其可作药用的盐类的化学结构式为:The present invention relates to a method for producing new antiparasitic substance, JEITACINS (JEITACINS) and its salts, which can be extracted from microbial culture. The chemical structural formula of the antibiotic and its pharmaceutically acceptable salts is:
式中:R=异丙基或异丁基In the formula: R = isopropyl or isobutyl
已经知道,作为抗寄生虫的药物,在抗生素中,有奥佛麦菌素(AVERMECTIN)、巴龙霉素(PAROMOMYCIN),在合成药中,有左旋咪唑(LEVAMISOLE)、氯硝柳胺(NICLOSAMIDE)等。这些药物作为医药品和动物药被用于治疗线虫病、丝虫病等,其效果是肯定的。但是,已知的抗寄生虫药物具有毒性、副作用或耐药性等问题。It is already known that as anti-parasitic drugs, among antibiotics, there are AVERMECTIN (AVERMECTIN) and paromomycin (PAROMOMYCIN), and among synthetic drugs, there are levamisole (LEVAMISOLE), niclosamide (NICLOSAMIDE) )wait. These medicines are used as medicines and animal medicines to treat nematodes, filariasis, etc., and their effects are certain. However, known antiparasitic drugs have problems of toxicity, side effects, or drug resistance.
本发明的目的,是要寻找毒副作用更小的抗寄生虫药物,以期提供有抗寄生虫活性的物质,解决人和动物治疗中的需求。The object of the present invention is to search for antiparasitic drugs with less toxic and side effects, in order to provide substances with antiparasitic activity and solve the needs in human and animal treatment.
本发明的要点,是以探索新的生物活性物质为目标,从不同土壤样品中分离菌种,并对其产物进行研究。结果发现了KP-197菌株,在其培养物中含有抑制寄生虫运动活性的物质。从该菌株的培养物中分离和精制出两个抑制寄生虫运动活性的纯物质。研究了这两个物质的理化特性,测定了其化学结构。具有这种化学结构的物质,尚未见到报道。这些物质统称为戒台霉素(JEITACINS)。结构式中R为异丙基的化合物叫戒台霉素A(JEITACINS A),R为异丁基的化合物叫戒台霉素B(JEITACINS B)。戒台霉素A和戒台霉素B的理化性质如下:The gist of the present invention is to isolate strains from different soil samples and to study their products with the aim of exploring new biologically active substances. As a result, the KP-197 strain was found, and its culture contained substances that inhibited the motility activity of the parasite. Two pure substances inhibiting the locomotor activity of the parasite were isolated and refined from the culture of this strain. The physical and chemical properties of these two substances were studied and their chemical structures were determined. Substances with this chemical structure have not been reported yet. These substances are collectively referred to as JEITACINS. The compound in which R is isopropyl in the structural formula is called JEITACINS A (JEITACINS A), and the compound in which R is isobutyl is called JEITACINS B (JEITACINS B). The physical and chemical properties of Tymycin A and Tymycin B are as follows:
戒台霉素A:Withdrawal from Tymycin A:
(1)白色粉末(1) white powder
(2)元素分析(2) Elemental analysis
C18H34N2O2 C 18 H 34 N 2 O 2
计算值:C69.57;H11.04;N9.02%Calculated value: C69.57; H11.04; N9.02%
实验值:C70.40;H11.09;N7.68%Experimental value: C70.40; H11.09; N7.68%
(3)分子量及分子式(3) Molecular weight and molecular formula
戒台霉素A的质谱,在m/z311处有(M+H)+的分子离子峰;在高分辨率质谱分析中,在m/z293处有(M-OH)+的离子峰。由此确定,其分子式C18H34N2O2,分子量是310。In the mass spectrum of Taimycin A, there is a (M+H) + molecular ion peak at m/z311; in high-resolution mass spectrometry, there is a (M-OH) + ion peak at m/z293. From this, it was determined that its molecular formula was C 18 H 34 N 2 O 2 , and its molecular weight was 310.
(4)紫外吸收光谱(4) UV absorption spectrum
如图1所示,在228mm处有一个特征性的吸收峰;在250nm处出现一个肩峰。As shown in Figure 1, there is a characteristic absorption peak at 228 nm; a shoulder peak appears at 250 nm.
(5)红外吸收光谱(5) Infrared absorption spectrum
用KBr溶剂法测定,如图2所示,其主要吸收极大波数如下:2950、2870、1705、1475、1415、1380、1270、1090、960(cm-1)。Measured by KBr solvent method, as shown in Figure 2, the main absorption maximum wave numbers are as follows: 2950, 2870, 1705, 1475, 1415, 1380, 1270, 1090, 960 (cm -1 ).
(6)核磁共振谱(6) NMR spectrum
使用瓦利安XL-400,400MH核磁共振仪,在重氯仿中测定的1H核磁共振谱如图3所示。Using Varian XL-400, 400MH nuclear magnetic resonance instrument, the 1 H nuclear magnetic resonance spectrum measured in heavy chloroform is shown in FIG. 3 .
(7)呈色反应(7) Color reaction
对甲氧基苯甲醛-硫酸 阳性p-methoxybenzaldehyde-sulfuric acid Positive
高锰酸钾 阳性Potassium permanganate Positive
硫酸 阴性sulfuric acid negative
德拉根道夫试验 阴性Dragendorff test negative
(8)溶解性(8) Solubility
溶于丙酮、乙酸乙酯、氯仿、己烷、二甲基亚砜。不溶于甲醇、水。Soluble in acetone, ethyl acetate, chloroform, hexane, dimethyl sulfoxide. Insoluble in methanol and water.
(9)化学结构(9) Chemical structure
上述技术领域阐明的结构式中,R为异丙基的结构式,是根据(1)-(9)所列理化性质与已知类似化合物进行比较得到的,它是14-甲基-1-乙烯偶氮氧15-烷-8酮。Among the structural formulas elucidated in the above technical field, R is the structural formula of isopropyl, which is obtained by comparing the physical and chemical properties listed in (1)-(9) with known similar compounds. It is 14-methyl-1-vinyl diisopropyl Nitroxide 15-alkan-8-one.
戒台霉素B:Withdrawal from Tymycin B:
(1)无色油状物(1) Colorless oil
(2)分子式,在高分辨质谱分析中,于m/z307处有(M-N)离子峰,由此确定起其分子式为C19H26N2O2,分子量为324。(2) Molecular formula. In the high-resolution mass spectrometry analysis, there is (MN) ion peak at m/z307, so its molecular formula is determined to be C 19 H 26 N 2 O 2 , and its molecular weight is 324.
(3)紫外吸收光谱(3) UV absorption spectrum
同戒台霉素ATymycin A
(4)红外吸收光谱(4) Infrared absorption spectrum
同戒台霉素ATymycin A
(5)呈色反应(5) Color reaction
同戒台霉素ATymycin A
(6)溶解性(6) Solubility
同戒台霉素ATymycin A
(7)化学结构(7) Chemical structure
戒台霉素B是戒台霉素A的类似物,两者在烷基侧链上的炭原子数不同。Tetramycin B is an analog of tetramycin A, and the number of carbon atoms on the alkyl side chain is different.
上述技术领域阐明的结构式中,R是异丁基的结构式,是根据(1)-(7)所列理化性质与已知化合物进行比较得到的结果,它是15-甲基-1-乙烯偶氮氧基16烷-8酮。Among the structural formulas elucidated in the above technical field, R is the structural formula of isobutyl, which is the result of comparing the physical and chemical properties listed in (1)-(7) with known compounds. It is 15-methyl-1-vinyl Nitroxide 16-alkan-8-one.
能产生戒台霉素的微生物属于链霉菌属,例如在本发明中分离到的链霉菌属的KP-197菌株,是在本发明中使用的最有效菌株之一。该菌株的分类学特性如下:Microorganisms capable of producing tinomycin belong to the genus Streptomyces, for example, the KP-197 strain of Streptomyces isolated in the present invention is one of the most effective strains used in the present invention. The taxonomic characteristics of this strain are as follows:
(1)在各种培养基上的营养菌丝发达,未观察到菌丝断裂。在淀粉无机盐培养基上,气生菌丝很稀少,白色,显微镜观察发现,孢子丝是直线状,孢子链由20个以上孢子组成,孢子大小为0.7-1.0×0.7μm,圆柱形,孢子表面光滑,未发现菌核,孢子囊以及游动孢子。(1) The vegetative hyphae developed on various media, no hyphae breakage was observed. On the starch inorganic salt medium, the aerial hyphae are very rare and white. Microscopic observation shows that the spore filaments are linear, and the spore chain is composed of more than 20 spores. The spore size is 0.7-1.0×0.7μm, cylindrical, spore The surface is smooth, no sclerotia, sporangia and zoospores were found.
(2)在各种培养基上的特征:(2) Characteristics on various media:
用塞戈瓦(E.B.SHIRLING和D.G.GOTTLIEB-国际系统细菌学杂志16卷313页,1966年)法研究该产生菌的培养特征,结果如表所示:(见第3页表)The cultural characteristics of the producing bacteria were studied by the method of Segova (E.B.SHIRLING and D.G.GOTTLIEB-International Journal of Systematic Bacteriology, Volume 16, Page 313, 1966), and the results are shown in the table: (see the table on page 3)
(3)生理特性(3) Physiological characteristics
黑色素形成 阳性melanin formation positive
酪氨酸琼脂 阳性Tyrosine agar Positive
蛋白胨酵母膏铁琼脂 阳性Peptone Yeast Extract Iron Agar Positive
葡萄糖蛋白胨明胶培养基(21-23℃) 阳性Glucose peptone gelatin medium (21-23°C) Positive
胰蛋白胨酵母膏液体培养基 阳性Tryptone Yeast Extract Liquid Medium Positive
酪氨酸酶反应 阳性Tyrosinase reaction positive
硫化氢的产生 阴性Hydrogen sulfide production Negative
硝酸盐还原 阳性Nitrate reduction Positive
明胶液化(葡萄糖、蛋白胨、明胶培养基)(21-23℃) 阳性Gelatin liquefaction (glucose, peptone, gelatin medium) (21-23°C) Positive
淀粉水解 阳性Starch hydrolysis Positive
牛奶凝固(37℃) 阴性Milk coagulation (37°C) Negative
牛奶胨化(37℃) 阳性Milk peptonization (37°C) Positive
生卡温度范围 15-38℃Card temperature range 15-38℃
炭源利用(采用普戈瓦PRIDHOM-GOTTLIEB琼脂作为基础培养基):Carbon source utilization (using Pugova PRIDHOM-GOTTLIEB agar as basal medium):
利用:D-葡萄糖,D-果糖、甘露糖Utilize: D-glucose, D-fructose, mannose
稍利用:D-甘露醇,(-阿拉伯糖,D-木糖、蔗糖,Slight use: D-mannitol, (-arabinose, D-xylose, sucrose,
不利用:L-鼠李糖,I-肌醇、棉子糖、密二糖、水杨酸。Do not use: L-rhamnose, I-inositol, raffinose, mebiose, salicylic acid.
纤维素分解 阴性Cellulolysis Negative
(4)细胞壁组成(4) Cell wall composition
细胞壁的二氨基庚二酸(DAP)是LL-DAP。The diaminopimelic acid (DAP) of the cell wall is LL-DAP.
综上所述,该菌株的分类学特征可以归纳如下:细胞壁的二氨基庚二酸是LL-DAP,孢子丝的形状是直线形,孢子链,孢子表面光滑,营养菌丝为米色,气生菌丝为白色,形成黑色素。由此可以确定,该菌株属链霉菌属(STREPTOMYCES)的一种。根据普柴氏分类法(PRIDHAM AND TRESNER)(伯述瓦细菌分类手册第八版748-829页,1974年),确认该产生的菌株属于白色系列的一种。In summary, the taxonomic features of this strain can be summarized as follows: the diaminopimelic acid in the cell wall is LL-DAP, the shape of the sporocystosis is linear, the spore chain, the spore surface is smooth, the vegetative hyphae are beige, aerial The hyphae are white and form melanin. It can be determined that the strain belongs to the genus Streptomyces (STREPTOMYCES). According to Puchai's classification method (PRIDHAM AND TRESNER) (Pg. 748-829, eighth edition of the Handbook of Bacteria Classification of Bethwa, 1974), it was confirmed that the produced strain belonged to the white series.
在本发明中,作为在培养基中的微生物的例子,首先使用了能产生戒台霉素的属于链霉菌属的微生物。然而,只要能产生戒台霉素的该菌株的变株,在本发明中亦可使用。In the present invention, as an example of the microorganisms in the culture medium, first, microorganisms belonging to the genus Streptomyces capable of producing streptomycin were used. However, as long as a mutant of the strain can produce orthotymycin, it can also be used in the present invention.
作为培养基,可以使用合成培养基或天然培养基。这些培养基通常含有适于培养放线菌的碳源、氮源和无机盐类以及适量必要的其它营养物质。As the medium, a synthetic medium or a natural medium can be used. These mediums generally contain carbon sources, nitrogen sources and inorganic salts suitable for cultivating actinomycetes, as well as appropriate and necessary other nutrients.
培养基中的碳源可以使用葡萄糖、甘油、果糖、麦芽糖、甘露糖、木糖、半乳糖、核糖、淀粉及其水解物等各种碳水化合物,使用浓度通常为0.1-5%。此外还有葡萄糖酸、丙酮酸、乳酸、醋酸等有机酸、甘氨酸、谷氨酸、丙氨酸等氨基酸、甲醇、乙醇等醇类化合物,以及正链烷烃等非芳香族碳氢化合物或者动植物的各种油脂类均可使用。Various carbohydrates such as glucose, glycerol, fructose, maltose, mannose, xylose, galactose, ribose, starch and its hydrolyzate can be used as the carbon source in the medium, and the use concentration is usually 0.1-5%. In addition, there are organic acids such as gluconic acid, pyruvic acid, lactic acid and acetic acid, amino acids such as glycine, glutamic acid and alanine, alcohol compounds such as methanol and ethanol, and non-aromatic hydrocarbons such as n-paraffins or animal and plant All kinds of oils can be used.
作为氮源,可以使用铵、氯化铵、磷酸铵、硫酸铵、硝酸铵等无机酸或有机酸铵盐、尿素、蛋白胨、NZ-胺、肉膏、酵母膏、干酵母、玉米浆、酪蛋白水解物、鱼粉或其水解物、大豆粉或其水解物、脱脂大豆或其水解物等含氮有机物质。还有甘氨酸、谷氨酸、丙氨酸等氨基酸。无机盐类使用各种磷酸盐、硫酸盐、食盐等以及微量的重金属盐类。As a nitrogen source, ammonium, ammonium chloride, ammonium phosphate, ammonium sulfate, ammonium nitrate and other inorganic or organic acid ammonium salts, urea, peptone, NZ-amine, meat extract, yeast extract, dry yeast, corn steep liquor, cheese Nitrogen-containing organic substances such as protein hydrolyzate, fish meal or its hydrolyzate, soybean meal or its hydrolyzate, defatted soybean or its hydrolyzate, etc. There are also amino acids such as glycine, glutamic acid, and alanine. Inorganic salts use various phosphates, sulfates, table salts and trace amounts of heavy metal salts.
在使用有特殊营养要求的变异株时,必须在培养基中添加能满足其营养要求的物质。这样的营养物质,在使用含有天然物质的培养基时,不须特别添加补充。When using mutant strains with special nutritional requirements, substances that can meet their nutritional requirements must be added to the medium. Such nutrients do not need to be specially supplemented when using a medium containing natural substances.
发酵培养,通常是在振动或通气搅拌等好气条件下进行。实际生产时是采用深层通气搅拌培养。培养基的pH值可以是5-8,但一般以中性pH较好。培养温度可以为20-40℃,但一般在26-32℃较好(理想温度为27℃左右)。液体培养基时间通常为3-6日,戒台霉素的效价达到最高峰时停止培养。培养基成份、培养温度、搅拌速度、通气量等培养条件,根据使用的菌株和外界条件可适当调整选定,液体培养出现泡沫时可适当选用硅酮树脂、植物油等表面活性剂消沫。Fermentation culture is usually carried out under aerobic conditions such as vibration or aeration and stirring. The actual production is to adopt deep aeration and stirring culture. The pH value of the medium can be 5-8, but generally neutral pH is better. The culture temperature can be 20-40°C, but generally 26-32°C is better (the ideal temperature is around 27°C). The time of liquid culture medium is usually 3-6 days, and the culture is stopped when the titer of ortamycin reaches the highest peak. Culture conditions such as culture medium composition, culture temperature, stirring speed, and air flow can be adjusted and selected according to the strains used and external conditions. When foam occurs in liquid culture, surfactants such as silicone resin and vegetable oil can be used to eliminate foam.
用上述方法在培养物中积累的戒台霉素,通常存在于培养液中。为了从培养滤液中提取戒台霉素,一般采用从微生物培养物中提取代谢产物的方法。这些方法可以单独或者随意结合或者反复使用。例如:过滤、离心、透析、浓缩、干燥、冷冻、吸附、洗脱;对各种溶媒溶解度不同的方法(如沉淀、结晶、重结晶、转溶、逆流配布),层析等方法。Tetramycin accumulated in culture by the method described above is usually present in the culture medium. In order to extract tyramycin from the culture filtrate, the method of extracting metabolites from microbial cultures is generally used. These methods can be used alone or in combination or repeatedly. For example: filtration, centrifugation, dialysis, concentration, drying, freezing, adsorption, elution; methods with different solubility of various solvents (such as precipitation, crystallization, recrystallization, transfer, countercurrent distribution), chromatography and other methods.
由于戒台霉素主要产生在培养液中,因此为了分离、提取该化合物,首先从培养液中除去菌体,然后再从培养滤液中提取该物质。Since tatyramycin is mainly produced in the culture fluid, in order to separate and extract the compound, first remove the bacteria from the culture fluid, and then extract the substance from the culture filtrate.
为了从培养滤液中提取戒台霉素,使用非亲水性的有机溶媒如乙酸乙脂等抽提,或者用活性炭、氧化铝、多孔性高分子合成树脂、离子交换树脂等进行吸附,再用乙酸乙脂等溶媒洗脱,得到的提取液或洗脱液进行减压浓缩,再用己烷等提取。这样得到的粗提物,用通常精制脂溶性物质的方法如硅胶或氧化铝柱层析等进行精制。In order to extract Tyramycin from the culture filtrate, use non-hydrophilic organic solvents such as ethyl acetate to extract, or use activated carbon, aluminum oxide, porous polymer synthetic resin, ion exchange resin, etc. to adsorb, and then use Elute with a solvent such as ethyl acetate, and the obtained extract or eluate is concentrated under reduced pressure, and then extracted with hexane or the like. The crude extract thus obtained is purified by a usual method for refining fat-soluble substances, such as silica gel or alumina column chromatography.
该化合物可作药用的盐类如盐酸盐、硫酸盐、硝酸盐、磷酸盐、碳酸盐、酒石酸盐、柠檬酸、琥珀酸盐等,使用常规方法可以制备。The compound can be used as pharmaceutically acceptable salts such as hydrochloride, sulfate, nitrate, phosphate, carbonate, tartrate, citric acid, succinate, etc., which can be prepared by conventional methods.
本发明的优点和积极效果是,用上述方法制备的活性物质,其抗寄生虫幕钚员认钟幸┪锴浚涠拘匀幢认钟幸┪锏汀>咛迨笛槭且运墒飨叱妫˙URSAPHLENCHUS LIGNICLOUS)作为治疗对象,采用木村等介绍的方法(AGRICULTURE BIOLOGICAI CHEMISRY 45,249,1981)测定戒台霉素抑制松树线虫的运动活性,其结果是:The advantages and positive effects of the present invention are that the active substance prepared by the above-mentioned method has anti-parasitic properties. XI Gui˙URSAPHLENCHUS LIGNICLOUS) was used as the treatment object, and the method introduced by Kimura et al. (AGRICULTURE BIOLOGICAI CHEMISRY 45, 249, 1981) was used to measure the locomotor activity of Tymycin in inhibiting pine nematodes, and the results were as follows:
戒台霉素A对线虫的致死率(%)The lethality rate of nematodes from Tymycin A (%)
0.5ug/ml 100%0.5ug/
0.25ug/ml 100%0.25ug/
0.125ug/ml 99%0.125ug/ml 99%
0.063ug/ml 86%0.063ug/ml 86%
戒台霉素B对线虫的致死率(%)The lethality rate of nematodes caused by Tymycin B (%)
0.5ug/ml 100%0.5ug/
0.25ug/ml 100%0.25ug/
0.125ug/ml 93%0.125ug/ml 93%
0.063ug/ml 80%0.063ug/
已知药物AVERMECTIN BLA对线虫的致死率(%)Lethality of the known drug AVERMECTIN BLA to nematodes (%)
5ug/ml 100%5ug/
2.5ug/ml 100%2.5ug/
1.25ug/ml 64%1.25ug/ml 64%
0.63ug/ml 58%0.63ug/ml 58%
从以上比较试验以看出,戒台霉素的抗寄生虫活性比已知药物强十倍以上,前者疗效明显优于后者。From the above comparative tests, it can be seen that the antiparasitic activity of Tymycin is more than ten times stronger than that of known drugs, and the curative effect of the former is obviously better than that of the latter.
急性毒性试验是用小鼠作为实验动物,经腹腔途径注射戒台霉素10mg/kg不致死,用相同方法观察已知药AVERMECTIN BLA的急性毒形,结果小鼠死亡。可见,戒台霉素的急性低于已知抗寄生虫药物。In the acute toxicity test, mice were used as experimental animals. Tymycin 10 mg/kg was not lethal by intraperitoneal injection. The acute toxicity of the known drug AVERMECTIN BLA was observed in the same way, and the mice died as a result. It can be seen that the acuteness of quitting Tyromycin is lower than that of known antiparasitic drugs.
以上活性及毒性试验表明,本发明所得到的戒台霉素,作为人、动物和植物的抗寄生虫药是有用的。The above activity and toxicity tests show that the tatyramycin obtained in the present invention is useful as an antiparasitic drug for humans, animals and plants.
实施例:Example:
在500ml板口瓶中装入100ml培养基(培养基成份:葡萄糖0.1%,马铃薯淀粉0.4%,蛋白胨0.5%,肉膏0.3%,酵母膏0.5%,碳酸钙0.4%,pH7.0),121℃,15分钟蒸汽灭菌后,将一白金耳的KP-197的斜面培养物(其成份:甘油1.0%,苹果酸钙1.0%,酵母膏0.1%,琼脂1.5%)种入上述灭菌的培养基中,在旋转摇床上27℃培养三天,将该培养作为种子。备30升的发酵罐二个,每个装入15升培养基(发酵培养基成份:甘油2.0%,黄豆粉2.0%,NaCl0.3%,瓜氨酸0.01%,CoCl0.002%,pH7.0),121℃30分钟蒸汽灭菌后,往每个发酵罐中种入6瓶上述种子,搅拌速度250r.p.m通气量15升/分,27℃120小时培养。Put 100ml of culture medium in a 500ml plate mouth bottle (medium composition: glucose 0.1%, potato starch 0.4%, peptone 0.5%, meat extract 0.3%, yeast extract 0.5%, calcium carbonate 0.4%, pH7.0), 121 ℃, 15 minutes after steam sterilization, a slant culture of white gold ear KP-197 (composition: 1.0% glycerol, 1.0% calcium malate, 0.1% yeast extract, 1.5% agar) was planted into the above-mentioned sterilized The medium was cultured on a rotary shaker at 27° C. for three days, and the culture was used as a seed. Prepare two 30-liter fermentation tanks, each filled with 15 liters of medium (composition of fermentation medium: glycerin 2.0%, soybean powder 2.0%, NaCl 0.3%, citrulline 0.01%, CoCl 0.002%, pH7. 0), after steam sterilization at 121°C for 30 minutes, 6 bottles of the above-mentioned seeds were planted into each fermenter, the stirring speed was 250r.p.m, the ventilation rate was 15 liters/min, and the culture was carried out at 27°C for 120 hours.
培养物离心(10,000r.p.m),分离菌体和培养液,得到上清液30升,用6NHCl将上述清液的pH值调至3.0,再离心,得到沉淀物,往沉淀物中加入15升50%丙酮溶液,搅拌,提取,过滤,得到提取液,将其减压浓缩至6升,加入3升乙酸乙酯,振动提取二次,得到的乙酸乙酯提取液,减压浓缩,得到油状粗提物,往粗提物中加入750ml己烷,提取两次得到己烷提取液,减压浓缩,得到粗制品4克,粗制品装入硅胶柱(马克公司制,ART7734,160克)层析,用己烷-乙酸乙酯溶液(30∶1)溶出,分份收集,各部份用松树线虫进行生物检定,活性部份合并,减压浓缩,得到粗制品30毫克,溶于少量氯仿中,每次取1/20的量进样,用反向分离柱(山村化学研究所制,AM324(ODS,10×300mm)进行高压液相层析,用60%乙腈水洗出,流速每分钟2毫升,收集显示保留时间18.5分与19.6分的各峰的活性部份,减压浓缩干燥,分别得到戒台霉素A7.2毫克和戒台霉素B5毫克。Centrifuge the culture (10,000r.p.m), separate the bacteria and the culture medium, obtain 30 liters of supernatant, adjust the pH value of the above supernatant to 3.0 with 6N HCl, and then centrifuge to obtain a precipitate, add 15 liters of 50% acetone solution, stirred, extracted, and filtered to obtain the extract, which was concentrated under reduced pressure to 6 liters, added with 3 liters of ethyl acetate, extracted twice by vibration, and the obtained ethyl acetate extract was concentrated under reduced pressure, Obtain oily crude extract, add 750ml hexane to the crude extract, extract twice to obtain hexane extract, concentrate under reduced pressure to obtain 4 grams of crude product, crude product is packed into silica gel column (manufactured by Mark Company, ART7734, 160 grams ) chromatography, eluted with hexane-ethyl acetate solution (30:1), collected in fractions, each part was used for biological assay with pine nematode, the active parts were combined, concentrated under reduced pressure to obtain 30 mg of crude product, dissolved in In a small amount of chloroform, 1/20 of the amount was injected each time, and high-pressure liquid chromatography was performed on a reverse separation column (manufactured by Yamamura Chemical Research Institute, AM324 (ODS, 10×300mm), washed with 60% acetonitrile water, and the flow rate 2 milliliters per minute, collect the active parts of the peaks showing retention times of 18.5 minutes and 19.6 minutes, concentrate and dry under reduced pressure to obtain 7.2 mg of Tetramycin A and 5 mg of Tetramycin B respectively.
附图说明:Description of drawings:
图1,戒台霉素A的紫外吸收光谱(在环己烷中测定)Figure 1. The UV absorption spectrum of Tetramycin A (determined in cyclohexane)
图2,戒台霉素A的红外吸收光谱(在KBr溶液中测定)Figure 2, Infrared Absorption Spectrum of Tetramycin A (measured in KBr solution)
图3,戒台霉素A的质子的核磁共振谱(在重氯仿中测定)Figure 3. The NMR spectrum of the protons of Tymycin A (determined in heavy chloroform)
Claims (7)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 88100187 CN1027905C (en) | 1988-01-27 | 1988-01-27 | The manufacture method of katymycin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 88100187 CN1027905C (en) | 1988-01-27 | 1988-01-27 | The manufacture method of katymycin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1034580A true CN1034580A (en) | 1989-08-09 |
| CN1027905C CN1027905C (en) | 1995-03-15 |
Family
ID=4831221
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 88100187 Expired - Fee Related CN1027905C (en) | 1988-01-27 | 1988-01-27 | The manufacture method of katymycin |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1027905C (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102533869A (en) * | 2012-01-13 | 2012-07-04 | 高丙利 | Actinomycete preparation and application thereof in aspect of controlling plant parasitic nematodes |
| CN107501131A (en) * | 2017-08-30 | 2017-12-22 | 山东省农药科学研究院 | One kind guards against platform mycin analog and preparation method thereof |
-
1988
- 1988-01-27 CN CN 88100187 patent/CN1027905C/en not_active Expired - Fee Related
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102533869A (en) * | 2012-01-13 | 2012-07-04 | 高丙利 | Actinomycete preparation and application thereof in aspect of controlling plant parasitic nematodes |
| CN102533869B (en) * | 2012-01-13 | 2014-12-17 | 高丙利 | Actinomycete preparation and application thereof in aspect of controlling plant parasitic nematodes |
| CN107501131A (en) * | 2017-08-30 | 2017-12-22 | 山东省农药科学研究院 | One kind guards against platform mycin analog and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1027905C (en) | 1995-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR900004066B1 (en) | Preparation of Biologically Active WS 6049 | |
| US5013550A (en) | Antibiotics called "chloropolysporins B and C", a process for their preparation, and their therapeutic and veterinary use | |
| JPS6244553B2 (en) | ||
| KR20020092899A (en) | Antibiotic caprazamycins and process for producing the same | |
| CN1034580A (en) | The manufacture method of a kind of antiparasitic new antibiotic and its esters | |
| SU751332A3 (en) | Method of preparing a-35512 antibiotic complex | |
| EP0236110B1 (en) | Animal growth promoting agents | |
| JPH0686682A (en) | Production of 4',7,8-trihydroxyisoflavone | |
| CN1039617A (en) | By 4 '-deoxidation-4 '-new antineoplastic agent that the microorganism Stereoselective reduction of iododoxorubicin obtains | |
| CA1302927C (en) | Efomycin g, its preparation and its use as a yield promoter in animals | |
| JP2594167B2 (en) | Novel antibiotic SF2698 substance and its production method | |
| JPS60141293A (en) | Novel carcinostatic antibiotic substance 81-484 and its production | |
| JP3530563B2 (en) | KO-8119 substance and process for producing the same | |
| RU2120997C1 (en) | Method of producing 2-amino-4-(hydroxymethyl)-3a,5,6,6a- -tetrahydro-4h-cyclopent-[d]-oxazole-4,5,6-triol and strains of actinomyces micromonospora and amycolatopsis producing its | |
| JPS6212227B2 (en) | ||
| JP2971204B2 (en) | New substance WK-2955 and method for producing the same | |
| FI106026B (en) | Process for the preparation of 2-amino-4- (hydroxymethyl) -3a, 5,6,6a-tetrahydro-4H-cyclopent [d] oxazole-4,5,6-triol | |
| CN1022765C (en) | Preparation method of cell variety mycomycin of new antibiotic | |
| JPH0367077B2 (en) | ||
| JPS6366155A (en) | Novel antibiotic jietacins and manufacture | |
| JPS61170396A (en) | Novel carcinostatic antibiotic substance 83-16-a and preparation thereof | |
| JPS6115694A (en) | Antibiotic nitracidomycins a and b and their preparation | |
| JPS60192593A (en) | Fr-900462 substance | |
| JPH01290673A (en) | New substance K3543R1, its use and manufacture | |
| JPS63146797A (en) | Production of antibiotic chloropolysporin c |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |